Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

• Status: Not yet recruiting
• Trial end date: 2022-07-30
• Target enrollment: 0
• Participant gender: All

Summary

Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Liege
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Appendectomy or cholecystectomy surgery

Exclusion Criteria:

• Allergy to local anesthetics

• Intolerance to tramadol HCl

• Patient with peritonitis

• Pregnant women

• Surgery without laparoscopy

• Chronic pain before the operation